ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients.
The Journal of infectious diseases（2023）
摘要
Clinical Trials Registration ClinicalTrials.gov Identifier: NCT04518410.
更多查看译文
关键词
ACTIV-2, clinical trial, COVID-19, monoclonal antibodies
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要